Newsroom

Industry News

27 Feb

Lightlake Therapeutics Inc., Licensor Of A Treatment To Reverse Opioid Overdoses, To Webcast Live, At VirtualInvestorConferences.com March 5th

Lightlake invites individual and institutional investors to attend interactive real-time presentation on Lightlake’s progress with its opioid overdose reversal treatment and achievements in other areas. - Lightlake Therapeutics Inc. (“Lightlake”) (LLTP), a biopharmaceutical company developing addiction treatments based on its expertise in opioid antagonists, announced today that its Chief...

Read more

27 Feb

CymaBay to Present at Upcoming Investor Conferences

CymaBay Therapeutics, Inc. (CBAY) announced today that members of its senior management team are scheduled to present at three upcoming investor conferences detailed below. Cowen and Company 35th Annual Health Care Conference Boston Marriott Copley Place Hotel, Boston, MA Wednesday, March 4 10:00 – 10:30 a.m. EST 27thAnnual ROTH...

Read more

27 Feb

SUREPURE: Interest flows in

INVESTOR interest in SurePure, a Nasdaq-listed purification technology business with deep roots in SA, has shown a sudden spike this month. Shares in SurePure, which is headed by former Springbok rugby prop Guy Kebble, more than tripled from US5c to US18c after the release of an upbeat trading update...

Read more

26 Feb

Hydrocarb Reports Reserve Increase With NPV10 Rising to $55.9MM

Hydrocarb Energy Corporation (HECC) today announced its oil reserves rose 20.6 percent in the last trailing six month period. The company’s independent petroleum engineering report as of January 31, 2015 reflected proved reserves of 1,232,000 net barrels oil and 11,662 MMCF net gas. This reflects a proved reserve oil...

Read more

26 Feb

What Awaits Keryx Biopharmaceuticals (KERX) this Earnings? – Analyst Blog

Keryx Biopharmaceuticals, Inc. (KERX) is scheduled to report its fourth-quarter and full-year 2014 results on Feb 27, 2015. Keryx’s track record has been dismal in the first nine months of 2014 with the company reporting wider-than-expected losses in all of the last four quarters. The average earnings miss over...

Read more

26 Feb

BreastCancerAnswers.com: Breast Cancer Vaccines Hangout

BreastCancerAnswers.com: Breast Cancer Vaccines Hangout   Breastcanceranswers.com, a patient advocacy group is hosting: “Quest for a Breast Cancer Vaccine” Google Hangout – Join Us Today   Link to the Event Page Invite:  https://plus.google.com/events/c5mi8m6b66sc1n81a9irgfuo8i4 YouTube Video (for mobile users):  http://www.youtube.com/watch?v=VfgLCGfH61I   When TODAY! Thursday – February 26, 2015   Begins at 12:00 P.M. EST, 10:00...

Read more

26 Feb

Eco-Shift Power Corp (OTCQB: ECOP) Makes Further Progress Into UK Market by Receiving Accolades in the Canada Innovation Competition for the UK Green Building Sector

Eco-Shift Power (ECOP) (ECOP), one of Canada’s leading energy management and lighting firms, received accolades from the Canadian Trade Commissioner Service and the High of Canada in London for coming in second place in the 2015 Canada Innovation Competition for the UK Green Building Sector. The competition aims to...

Read more

26 Feb

Celator® Pharmaceuticals to Present at Roth Conference

Celator Pharmaceuticals, Inc. (CPXX), a biopharmaceutical company that is transforming the science of combination therapy and developing products to improve patient outcomes in cancer, today announced that Scott Jackson, Chief Executive Officer, will present an overview of the company at the 27th Annual Roth Conference on Monday, March 9,...

Read more

25 Feb

GeoVax Announces Equity Financing of Up to $6 Million

GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing innovative human vaccines using its novel platform technology, today announced that it has entered into a definitive agreement to sell up to $6 million of its equity securities to a single dedicated healthcare institutional investor. The closing of the transaction...

Read more

Page 1 of 4912345...102030...Last »

Latest Tweets